Literature DB >> 21198554

Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation.

S Jagtap1, K Meganathan, J Gaspar, V Wagh, J Winkler, J Hescheler, A Sachinidis.   

Abstract

BACKGROUND AND
PURPOSE: Teratogenic substances induce adverse effects during the development of the embryo. Multilineage differentiation of human embryonic stem cells (hESCs) mimics the development of the embryo in vitro. Here, we propose a transcriptomic approach in hESCs for monitoring specific toxic effects of compounds as an alternative to traditional time-consuming and cost-intensive in vivo tests requiring large numbers of animals. This study was undertaken to explore the adverse effects of cytosine arabinoside (Ara-C) on randomly differentiated hESCs. EXPERIMENTAL APPROACH: Human embryonic stem cells were used to investigate the effects of a developmental toxicant Ara-C. Sublethal concentrations of Ara-C were given for two time points, day 7 and day 14 during the differentiation. Gene expression was assessed with microarrays to determine the dysregulated transcripts in presence of Ara-C. KEY
RESULTS: Randomly differentiated hESCs were able to generate the multilineage markers. The low concentration of Ara-C (1 nM) induced the ectoderm and inhibited the mesoderm at day 14. The induction of ectodermal markers such as MAP2, TUBB III, PAX6, TH and NESTIN was observed with an inhibition of mesodermal markers such as HAND2, PITX2, GATA5, MYL4, TNNT2, COL1A1 and COL1A2. In addition, no induction of apoptosis was observed. Gene ontology revealed unique dysregulated biological process related to neuronal differentiation and mesoderm development. Pathway analysis showed the axon guidance pathway to be dysregulated. CONCLUSIONS AND IMPLICATIONS: Our results suggest that hESCs in combination with toxicogenomics offer a sensitive in vitro developmental toxicity model as an alternative to traditional animal experiments.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21198554      PMCID: PMC3081118          DOI: 10.1111/j.1476-5381.2010.01197.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

Review 1.  Embryoid bodies: an in vitro model of mouse embryogenesis.

Authors:  I Desbaillets; U Ziegler; P Groscurth; M Gassmann
Journal:  Exp Physiol       Date:  2000-11       Impact factor: 2.969

2.  High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells.

Authors:  Sabrina C Desbordes; Dimitris G Placantonakis; Anthony Ciro; Nicholas D Socci; Gabsang Lee; Hakim Djaballah; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

3.  Sox3 regulates both neural fate and differentiation in the zebrafish ectoderm.

Authors:  Chris T Dee; Caroline S Hirst; Yu-Huan Shih; Vineeta B Tripathi; Roger K Patient; Paul J Scotting
Journal:  Dev Biol       Date:  2008-05-24       Impact factor: 3.582

4.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

Review 5.  Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels.

Authors:  H Kuivaniemi; G Tromp; D J Prockop
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

6.  Identifying biological themes within lists of genes with EASE.

Authors:  Douglas A Hosack; Glynn Dennis; Brad T Sherman; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

7.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 8.  Bone metastasis: pathogenesis and therapeutic implications.

Authors:  Philippe Clezardin; Anna Teti
Journal:  Clin Exp Metastasis       Date:  2007-11-16       Impact factor: 5.150

Review 9.  Structural insight into Slit-Robo signalling.

Authors:  Erhard Hohenester
Journal:  Biochem Soc Trans       Date:  2008-04       Impact factor: 5.407

10.  Monoclonal antibodies discriminating netrin-G1 and netrin-G2 neuronal pathways.

Authors:  Kimie Niimi; Sachiko Nishimura-Akiyoshi; Toshiaki Nakashiba; Shigeyoshi Itohara
Journal:  J Neuroimmunol       Date:  2007-10-22       Impact factor: 3.478

View more
  15 in total

Review 1.  Teratogen screening with human pluripotent stem cells.

Authors:  Kathryn E Worley; Jennifer Rico-Varela; Dominic Ho; Leo Q Wan
Journal:  Integr Biol (Camb)       Date:  2018-09-17       Impact factor: 2.192

2.  Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation.

Authors:  Vaibhav Shinde; Stefanie Klima; Perumal Srinivasan Sureshkumar; Kesavan Meganathan; Smita Jagtap; Eugen Rempel; Jörg Rahnenführer; Jan Georg Hengstler; Tanja Waldmann; Jürgen Hescheler; Marcel Leist; Agapios Sachinidis
Journal:  J Vis Exp       Date:  2015-06-17       Impact factor: 1.355

3.  Gene-modified embryonic stem cell test to characterize chemical risks.

Authors:  Kohei Kitada; Akane Kizu; Takeshi Teramura; Toshiyuki Takehara; Masami Hayashi; Daisuke Tachibana; Hideki Wanibuchi; Shoji Fukushima; Masayasu Koyama; Kayo Yoshida; Takashi Morita
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-24       Impact factor: 4.223

4.  Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity.

Authors:  Aldert H Piersma; Nancy C Baker; George P Daston; Burkhard Flick; Michio Fujiwara; Thomas B Knudsen; Horst Spielmann; Noriyuki Suzuki; Katya Tsaioun; Hajime Kojima
Journal:  Curr Res Toxicol       Date:  2022-05-13

5.  Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.

Authors:  Anne K Krug; Raivo Kolde; John A Gaspar; Eugen Rempel; Nina V Balmer; Kesavan Meganathan; Kinga Vojnits; Mathurin Baquié; Tanja Waldmann; Roberto Ensenat-Waser; Smita Jagtap; Richard M Evans; Stephanie Julien; Hedi Peterson; Dimitra Zagoura; Suzanne Kadereit; Daniel Gerhard; Isaia Sotiriadou; Michael Heke; Karthick Natarajan; Margit Henry; Johannes Winkler; Rosemarie Marchan; Luc Stoppini; Sieto Bosgra; Joost Westerhout; Miriam Verwei; Jaak Vilo; Andreas Kortenkamp; Jürgen Hescheler; Ludwig Hothorn; Susanne Bremer; Christoph van Thriel; Karl-Heinz Krause; Jan G Hengstler; Jörg Rahnenführer; Marcel Leist; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2012-11-21       Impact factor: 5.153

Review 6.  Pluripotent Stem Cells in Developmental Toxicity Testing: A Review of Methodological Advances.

Authors:  Anthony L Luz; Erik J Tokar
Journal:  Toxicol Sci       Date:  2018-09-01       Impact factor: 4.849

7.  A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors.

Authors:  Eugen Rempel; Lisa Hoelting; Tanja Waldmann; Nina V Balmer; Stefan Schildknecht; Marianna Grinberg; John Antony Das Gaspar; Vaibhav Shinde; Regina Stöber; Rosemarie Marchan; Christoph van Thriel; Julia Liebing; Johannes Meisig; Nils Blüthgen; Agapios Sachinidis; Jörg Rahnenführer; Jan G Hengstler; Marcel Leist
Journal:  Arch Toxicol       Date:  2015-08-14       Impact factor: 5.153

8.  Identification of thalidomide-specific transcriptomics and proteomics signatures during differentiation of human embryonic stem cells.

Authors:  Kesavan Meganathan; Smita Jagtap; Vilas Wagh; Johannes Winkler; John Antonydas Gaspar; Diana Hildebrand; Maria Trusch; Karola Lehmann; Jürgen Hescheler; Hartmut Schlüter; Agapios Sachinidis
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

9.  Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells.

Authors:  K Meganathan; S Jagtap; S P Srinivasan; V Wagh; J Hescheler; J Hengstler; M Leist; A Sachinidis
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

10.  Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery.

Authors:  B Zimmer; G Pallocca; N Dreser; S Foerster; T Waldmann; J Westerhout; S Julien; K H Krause; C van Thriel; J G Hengstler; A Sachinidis; S Bosgra; M Leist
Journal:  Arch Toxicol       Date:  2014-04-02       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.